Afinum partners with A.R.C. Laser and neoLaser to form the MedTech Laser Group, enhancing capabilities in medical laser technologies through strategic investment.

Information on the Target

Afinum has partnered with Angela Thyzel, founder of A.R.C. Laser GmbH, and Gil Shapira, founder of G.N.S. neoLaser Ltd., to create an integrated leader in medical laser technologies through significant investments. By acquiring a majority stake in this new entity, Afinum positions itself to leverage the expertise and innovation of both founders, who will also reinvest in the venture.

A.R.C. Laser, based in Nuremberg, Germany, has been a pioneering player in medical laser technology since its inception in 1996. The company specializes in advanced laser technologies specifically for ophthalmic treatments, particularly addressing glaucoma and cataract procedures. With a robust focus on research and development, A.R.C. Laser has expanded its product range to include applications in surgical fields such as Laryngology, Otology, Rhinology, in addition to veterinary medicine. Conversely, neoLaser, established in 2012 in Caesarea, Israel, has rapidly gained recognition for its innovative laser systems and fibers used in Endovenous Laser Ablation and Proctology applications, leading to improved patient care and treatment results.

Industry Overview

The global market for ophthalmologic and surgical lasers is experiencing robust growth, driven by key trends including an aging population and a rising incidence of diseases requiring surgical intervention